参麦注射液在冠心病心绞痛患者中的治疗作用

The treatment effect of Shen-Mai injection in patients with angina pectoris

目的:探讨参麦注射液在治疗冠心病心绞痛患者中的作用。方法:选择92例冠心病心绞痛患者,对照组46例在常规治疗基础上加用低分子肝素,观察组46例加用参麦注射液,比较两组患者治疗前后心电图变化以及临床疗效。结果:治疗后观察组显效例数明显多于对照组,无效例数少于对照组,总临床疗效优于对照组(P<0.05),治疗后观察组患者ST段下移幅度和T波倒置幅度明显小于对照组,心绞痛发作次数亦小于对照组(P<0.05)。结论:在常规治疗的基础上,使用参麦注射液,具有活血化瘀,改善心功能等作用,对治疗冠心病心绞痛有利。

Objective： To investigate the role of Shen-Mai injection in patients with angina pectoris. Methods： Control group of 46 cases with low molecular weight heparin on the basis of conventional treatment while observation group of 46 cases with Shen-Mai injection, ECG changes before and after treatment and clinical efficacy were compared between two groups. Results： After treatment, the number of cases was marked, clinical efficacy of observation group was higher than control group, the number of valid cases was less than control group（P0.05）, after treatment ST segment depression and T wave inversion amplitude range of observation group were significantly less than control group, the number of angina attacks was less than control group （P0.05）. Conclusion： Shen-Mai injection on the basis of conventional therapy can unobstructed blood circulation, improve heart function and is advantageous for angina pectoris.